Amirhosein Sahebkar Selected Research

5-hydroxyuracil

6/2020

A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amirhosein Sahebkar Research Topics

Disease

8	Neoplasms (Cancer) 07/2023 - 01/2018
4	Inflammation (Inflammations) 12/2023 - 10/2018
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021 - 07/2018
2	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2024 - 02/2023
2	Ataxia (Dyssynergia) 12/2023 - 02/2023
2	Ototoxicity 07/2023 - 05/2023
2	Non-alcoholic Fatty Liver Disease 06/2021 - 06/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2018
2	Neoplasm Metastasis (Metastasis) 12/2018 - 02/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2023
1	Multiple Sulfatase Deficiency Disease (Mucosulfatidosis) 12/2023
1	Sensorineural Hearing Loss 05/2023
1	Cerebellar Ataxia (Dysmetria) 02/2023
1	Constipation 02/2023
1	Nausea 02/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Overweight 03/2021
1	Sleep Deprivation 03/2021
1	Epilepsy (Aura) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Infarction (Infarctions) 05/2020
1	Ischemic Stroke 05/2020
1	Brain Ischemia (Cerebral Ischemia) 05/2020
1	Circulating Neoplastic Cells 01/2019
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2019
1	Colitis-Associated Neoplasms 10/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2017
1	Papillomavirus Infections 05/2017
1	Infections 05/2017
1	Atherosclerosis 02/2015
1	Vascular Calcification 02/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015

Drug/Important Bio-Agent (IBA)

10	CurcuminIBA 06/2021 - 05/2017
3	acetylleucineIBA 04/2024 - 02/2023
3	DiarylheptanoidsIBA 01/2021 - 02/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2023
1	mesoglycanIBA 07/2023
1	ResveratrolIBA 07/2023
1	Cisplatin (Platino)FDA LinkGeneric 07/2023
1	HDL CholesterolIBA 12/2021
1	CytokinesIBA 01/2021
1	5-hydroxyuracilIBA 06/2020
1	EnzymesIBA 06/2020
1	UracilIBA 06/2020
1	DNA (Deoxyribonucleic Acid)IBA 06/2020
1	CytosineIBA 06/2020
1	Minocycline (Cyclops)FDA LinkGeneric 05/2020
1	Neuroprotective AgentsIBA 05/2020
1	Small Heat-Shock ProteinsIBA 01/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019
1	HSP27 Heat-Shock ProteinsIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 01/2019
1	AntibodiesIBA 01/2019
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 12/2018
1	Adenosine Monophosphate (AMP)IBA 12/2018
1	Protein Kinases (Protein Kinase)IBA 12/2018
1	Fluorouracil (Carac)FDA LinkGeneric 10/2018
1	Sulfhydryl Compounds (Thiols)IBA 10/2018
1	Cholesterol Ester Transfer ProteinsIBA 07/2018
1	PhytochemicalsIBA 02/2018
1	bisdemethoxycurcuminIBA 02/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	dimethoxycurcuminIBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2017
1	Benzo(a)pyreneIBA 05/2017
1	SmokeIBA 05/2017
1	CarcinogensIBA 05/2017
1	OsteopontinIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015

Therapy/Procedure

2	Therapeutics 12/2023 - 10/2018
2	Radiotherapy 05/2023 - 12/2018
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 12/2018